1. Heidari Horestani, Mehdi, Atri Roozbahani, Golnaz, Baniahmad, Aria. 2024. The clock gene BHLHE40 and atypical CCNG2 control androgen-induced cellular senescence as a novel tumor suppressive pathway in prostate cancer. In Journal of experimental & clinical cancer research : CR, 43, 174. doi:10.1186/s13046-024-03097-6. https://pubmed.ncbi.nlm.nih.gov/38902772/
2. Qin, W-J, Wang, W-P, Wang, X-B, Zhang, X-T, Du, J-D. . MiR-1290 targets CCNG2 to promote the metastasis of oral squamous cell carcinoma. In European review for medical and pharmacological sciences, 23, 10332-10342. doi:10.26355/eurrev_201912_19671. https://pubmed.ncbi.nlm.nih.gov/31841213/
3. Jensen, M R, Audolfsson, T, Keck, C L, Zimonjic, D B, Thorgeirsson, S S. . Gene structure and chromosomal localization of mouse cyclin G2 (Ccng2). In Gene, 230, 171-80. doi:. https://pubmed.ncbi.nlm.nih.gov/10216255/
4. Hasegawa, Shinichiro, Nagano, Hiroaki, Konno, Masamitsu, Doki, Yuichiro, Ishii, Hideshi. 2015. Cyclin G2: A novel independent prognostic marker in pancreatic cancer. In Oncology letters, 10, 2986-2990. doi:. https://pubmed.ncbi.nlm.nih.gov/26722276/
5. Ahmed, Shaimaa, Al-Saigh, Sarra, Matthews, Jason. . FOXA1 is essential for aryl hydrocarbon receptor-dependent regulation of cyclin G2. In Molecular cancer research : MCR, 10, 636-48. doi:10.1158/1541-7786.MCR-11-0502. https://pubmed.ncbi.nlm.nih.gov/22596188/
6. Mourgues, L, Imbert, V, Nebout, M, Mary, D, Peyron, J-F. 2015. The BMI1 polycomb protein represses cyclin G2-induced autophagy to support proliferation in chronic myeloid leukemia cells. In Leukemia, 29, 1993-2002. doi:10.1038/leu.2015.112. https://pubmed.ncbi.nlm.nih.gov/25925206/
7. Chen, Lingling, Tang, Jie, Chang, Yunli, Ji, Jieru, Chen, Guoyu. 2024. SMURF1 leads to the β-catenin signaling-mediated progression of esophageal squamous carcinoma by losing PATZ1-induced CCNG2 transcription. In Biochemical pharmacology, 232, 116688. doi:10.1016/j.bcp.2024.116688. https://pubmed.ncbi.nlm.nih.gov/39617210/